Trial intelligence / Profile preview

Aliskiren in heart transplant patients with hypertension

NCT01235910Phase 4Terminated

Sponsor
University of Colorado Denver
Start
May 2011
Primary completion
Dec 2012
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of aliskiren in hypertension (HTN), sponsored by University of Colorado Denver. Started May 2011; status: terminated.

02

Drugs

aliskiren
03

Conditions

hypertension (HTN)

Beyond the preview

Go deeper on NCT01235910.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01235910.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call